secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2021-07-15T23:59:59+00:00
Accession:  0001193125-21-216388
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viridian appoints Jennifer Moses, CPA to board and as Audit Committee Chair
---------------------------------------------------------------------------

- Appointed Jennifer Moses as Class II director and Chair of Audit Committee, effective July 14, 2021.
- Moses serves as CFO of G1 Therapeutics (GTHX) since 2019; previously partner at Rankin McKenzie.
- Receives $55k annual cash retainer; granted option for 25,000 shares at July 14 closing price, vesting over 3 years.
- CPA with B.S. in Accounting from Penn State; held roles at Deloitte including strategic planning.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/0001193125-21-216388-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/d200433d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-216388

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer